Acosta S, Alhadad A, Svensson P, Ekberg O
Vascular Centre, Malmö University Hospital, Malmö, Sweden.
Br J Surg. 2008 Oct;95(10):1245-51. doi: 10.1002/bjs.6319.
Epidemiological reports on risk and prognostic factors in patients with mesenteric venous thrombosis (MVT) are scarce.
Patients with MVT were identified through the inpatient and autopsy registry between 2000 and 2006 at Malmö University Hospital.
Fifty-one patients had MVT, diagnosed at autopsy in six. The highest incidence (11.3 per 100,000 person-years) was in the age category 70-79 years. Activated protein C resistance was present in 13 of 29 patients tested. D-dimer at admission was raised in all five patients tested. Multidetector row computed tomography (CT) in the portal venous phase was diagnostic in all 20 patients investigated, of whom 19 were managed conservatively. The median length of resected bowel in 12 patients who had surgery was 0.6 (range 0.1-2.2) m. The overall 30-day mortality rate was 20 percent; intestinal infarction (P = 0.046), treatment on a non-surgical ward (P = 0.001) and CT not done (P = 0.022) were associated with increased mortality. Cancer was independently associated with long-term mortality: hazard ratio 4.03, 95 percent confidence interval 1.03 to 15.85; P = 0.046.
Portal venous phase CT appeared sensitive in diagnosing MVT. As activated protein C resistance was a strong risk factor, lifelong anticoagulation should be considered.
关于肠系膜静脉血栓形成(MVT)患者的风险及预后因素的流行病学报告较为匮乏。
通过马尔默大学医院2000年至2006年的住院患者及尸检登记记录来确定MVT患者。
51例患者患有MVT,其中6例经尸检确诊。发病率最高(每10万人年11.3例)的年龄组为70 - 79岁。在接受检测的29例患者中,13例存在活化蛋白C抵抗。所有接受检测的5例患者入院时D - 二聚体均升高。在接受检查的20例患者中,门静脉期多排螺旋CT对所有患者均具有诊断价值,其中19例接受了保守治疗。12例接受手术的患者切除肠段的中位长度为0.6(范围0.1 - 2.2)米。30天总体死亡率为20%;肠梗死(P = 0.046)、在非外科病房接受治疗(P = 0.001)以及未进行CT检查(P = 0.022)与死亡率增加相关。癌症与长期死亡率独立相关:风险比4.03,95%置信区间1.03至15.85;P = 0.046。
门静脉期CT在诊断MVT方面似乎具有敏感性。由于活化蛋白C抵抗是一个强烈的风险因素,应考虑终身抗凝治疗。